1.15
-0.04(-3.36%)
Currency In USD
| Previous Close | 1.19 |
| Open | 1.17 |
| Day High | 1.22 |
| Day Low | 1.14 |
| 52-Week High | 19.2 |
| 52-Week Low | 1.1 |
| Volume | 51,486 |
| Average Volume | 154,241 |
| Market Cap | 8.24M |
| PE | 3.19 |
| EPS | 0.36 |
| Moving Average 50 Days | 1.45 |
| Moving Average 200 Days | 3.86 |
| Change | -0.04 |
If you invested $1000 in Calidi Biotherapeutics, Inc. (CLDI) since IPO date, it would be worth $11.76 as of December 31, 2025 at a share price of $1.15. Whereas If you bought $1000 worth of Calidi Biotherapeutics, Inc. (CLDI) shares 2 years ago, it would be worth $11.37 as of December 31, 2025 at a share price of $1.15.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Calidi Biotherapeutics Announces Exclusive Live Investor Webinar and Q&A Session on November 19, 2025
GlobeNewswire Inc.
Nov 17, 2025 1:00 PM GMT
SAN DIEGO, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genet
Calidi Biotherapeutics Presents New Data on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting and Holds Its First Investor Day at SITC
GlobeNewswire Inc.
Nov 10, 2025 1:00 PM GMT
SAN DIEGO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of systemically delivered, targeted genetic medicines, pr
Calidi Biotherapeutics Announces Investor Event to be Held on Friday, November 7th at the 2025 SITC Annual Meeting
GlobeNewswire Inc.
Nov 04, 2025 1:00 PM GMT
SAN DIEGO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of systemically delivered, targeted genetic medicines, to